Efficacy and Safety of Dupilumab for the Treatment of Severe Atopic Dermatitis in Clinical Practice: A Single Center Experience

Background: Dupilumab is a new targeted therapy for severe atopic dermatitis (AD) with limited real-world evidence. Objective: Explore our experience with dupilumab for AD in clinical practice at a tertiary care center. Material and method: Unicentric observational retrospective study including adul...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	A. Martínez-Doménech, V. Zaragoza-Ninet, A. Esteve-Martínez, A. García-Rabasco, J.L. Sánchez-Carazo, A. Pérez-Ferriols
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	Elsevier 2024-02-01
Serie:	Actas Dermo-Sifiliográficas
Ämnen:	Dermatitis atópica Tratamiento dermatológico Dupilumab Eccema Práctica clínica
Länkar:	http://www.sciencedirect.com/science/article/pii/S0001731023008189
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!